Page last updated: 2024-11-05

trazodone and Neurotic Disorders

trazodone has been researched along with Neurotic Disorders in 2 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peruzy, AD1
De Gregorio, M1
Favilli, S1
De Santis, AM1
Lehmann, HE1
Ban, TA1
Schwartz, GV1

Trials

2 trials available for trazodone and Neurotic Disorders

ArticleYear
[Statistical study on a new tranquilizing agent].
    La Clinica terapeutica, 1975, Jan-15, Volume: 72, Issue:1

    Topics: Adult; Clinical Trials as Topic; Diazepam; Drug Evaluation; Female; Humans; Male; Neurotic Disorders

1975
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161).
    International pharmacopsychiatry, 1975, Volume: 10, Issue:1

    Topics: Adult; Aged; Clinical Trials as Topic; Depression; Female; Humans; Male; Mental Disorders; Middle Ag

1975